Literature DB >> 4012

In vitro susceptibility studies with josamycin and erythromycin.

L J Strausbaugh, J A Dilworth, J M Gwaltney, M A Sande.   

Abstract

The in vitro activity of josamycin and erythromycin against five bacterial species was compared. In general, erythromycin was slightly more active by weight than josamycin, although both agents had a similar range of activity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 4012      PMCID: PMC429568          DOI: 10.1128/AAC.9.3.546

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  1 in total

1.  Detailed methodology and implementation of a semiautomated serial dilution microtechnique for antimicrobial susceptibility testing.

Authors:  J D MacLowry; M J Jaqua; S T Selepak
Journal:  Appl Microbiol       Date:  1970-07
  1 in total
  11 in total

1.  In vitro activity of rosamicin, josamycin, erythromycin, and clindamycin against beta-lactamase-nagative and beta-lactamase-positive strains of Neisseria gonorrhoeae.

Authors:  J W Biddle; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

2.  Comparison of josamycin and erythromycin in the therapy of Mycoplasma pneumoniae pneumonia.

Authors:  R P Wenzel; J O Hendley; W K Dodd; J M Gwaltney
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

3.  In vivo effects of josamycin, erythromycin, and placebo therapy on nasal carriage of Staphylococcus aureus.

Authors:  S Z Wilson; R R Martin; M Putman
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

4.  In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.

Authors:  J Santoro; D Kaye; M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

5.  Comparative pharmacology of josamycin and erythromycin stearate.

Authors:  L J Strausbaugh; W K Bolton; J A Dilworth; R L Guerrant; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

6.  Comparative in vitro activity of fleroxacin (RO 23-6240) against Ureaplasma urealyticum and Mycoplasma hominis.

Authors:  R Krausse; U Ullmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

7.  Susceptibility of anaerobic bacteria to 23 antimicrobial agents.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

8.  In vitro susceptibility of common clinical anaerobic and aerobic isolates against josamycin.

Authors:  R E Reese; R F Betts; L W Goedde; R G Douglas
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

9.  Medium for selective isolation of Fusobacterium nucleatum from human periodontal pockets.

Authors:  C B Walker; D Ratliff; D Muller; R Mandell; S S Socransky
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

10.  Mechanisms of macrolide resistance in Ureaplasma urealyticum: a study on collection and clinical strains.

Authors:  G Palù; S Valisena; M F Barile; G A Meloni
Journal:  Eur J Epidemiol       Date:  1989-06       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.